Senores Pharmaceuticals Q1 Results
- BSE: 544319
- NSE: SENORES
- ISIN: INE0RB801010
- Sector: Biotechnology & Drugs
BSE
961.55
29.10 (3.12%)
29.10 (3.12%)Volume23.08 K
Updated: Fri 8 May, 2026 | 15:29:24
NSE
965.5533.75 (3.62%)
33.75 (3.62%)Volume3.64 L
Updated: Fri 8 May, 2026 | 15:40:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Senores Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 109.82 | 100.00 | 9.82% | 62.59 | 75.46% |
| Depreciation/ Amortization | 5.99 | 5.23 | 14.53% | 3.52 | 70.17% |
| Operating Income | 28.17 | 14.21 | 98.24% | 17.80 | 58.26% |
| Net Income | 19.73 | 17.83 | 10.66% | 10.72 | 84.05% |
| Other Operating Expenses Total | 20.82 | 22.68 | -8.20% | 12.42 | 67.63% |
| Net Income Before Taxes | 26.49 | 20.68 | 28.09% | 13.46 | 96.81% |
| Total Revenue | 137.99 | 114.21 | 20.82% | 80.39 | 71.65% |
| Selling/ General/ Admin Expenses Total | 21.65 | 14.64 | 47.88% | 12.03 | 79.97% |
| Diluted Normalized EPS | 4.60 | 3.98 | 15.63% | 3.39 | 35.69% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.